skip to the content

Our Experts

Physician Profile

412-647-0104 Phone
412-647-2601 Fax

James M. Mountz, MD, PhD

Job Title Professor of Radiology
Job Title Chief of Nuclear Medicine
Job Title Director NeuroNuclear Medicine PET Facility, UPMC Presbyterian
Department of Pediatric Radiology
200 Lothrop St., Suite B-938
Pittsburgh, PA 15213
412-647-0104 Phone
412-647-2601 Fax
Email mountzjm@upmc.edu
Patient Appointment Information

Education and Training

Medical School:

1981 Case Western Reserve

Residency:

1984 University of Michigan
1984 Armed Forces Institute of Pathology

Fellowship:

1986 University of Michigan Medical Center

Memberships

  • American Medical Association
  • Radiological Society of America
  • The Society of Nuclear Medicine

Board Certifications

  • Diplomat, National Board of Medical Examiners
  • Diplomat, American Board of Radiology
  • Diplomat, American Board of Nuclear Medicine

Awards

  • Named by "Best Doctors" in Pittsburgh Region

Publications

  • Heron DE, Ferris RL, Karamouzis M, Andrade RS, Deeb EL, Burton S, Gooding WE, Branstetter BF, Mountz JM, Johnson JT, Argiris A, Grandis JR, Lai SY. Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial. Int J Radiat Oncol Biol Phys. 2009 May 21. [Epub ahead of print]
  • Laymon CM, Mason NS, Frankle WG, Carney JP, Lopresti BJ, Litschge MY, Mathis CA, Mountz JM, Narendran R. Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET. J Nucl Med. 2009 May;50(5):814-7. Epub 2009 Apr 16.
  • Narendran R, Frankle WG, Mason NS, Laymon CM, Lopresti BJ, Price JC, Kendro S, Vora S, Litschge M, Mountz JM, Mathis CA. Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies. Synapse. 2009 Jul;63(7):574-84.

    View Dr. Mountz 's full list of publications from PubMed.



Active Research Projects / Grants

  • 40. Gene Therapy of Diabetes in NOD Mouse Models. National Institute of Health. P.I., Huange-Ge Zhang, DVM, PhD, Investigators, John D. Mountz, M.D., Ph.D., Hui-Chen Hsu, Ph.D., James M. Mountz, M.D., Ph.D. Total Direct = $1,800,000.00 7/1/01-6/30/06.
Last Update
October 6, 2009
top
  • Increase/Decrease Text Size
  • Print This Page
top
Last Update
October 6, 2009
top